Shuttle Pharmaceuticals closed $4.25 million private placement to fund acquisitions

From GlobeNewswire: 2025-06-24 16:10:00

Shuttle Pharmaceuticals Holdings, Inc. closed a private placement, raising $4.25 million in gross proceeds for potential acquisitions and corporate purposes. The Company issued 1,180,877 shares of common stock at $3.60 per share through WestPark Capital, Inc. as the exclusive placement agent. Details will be available in a Form 8-K filing with the SEC. Shuttle Pharma focuses on improving outcomes for cancer patients undergoing radiation therapy, aiming to increase cure rates and patient survival while minimizing side effects. Forward-looking statements should be considered with caution. For more information, visit www.shuttlepharma.com.



Read more at GlobeNewswire: Shuttle Pharmaceuticals Announces Closing of $4.25 Million